The risk for diabetes was significantly greater among adults with gastroduodenal indolent lymphoma who underwent radiotherapy, compared with those who did not undergo radiotherapy. The findings, published in the journal Cancer Research and Treatment, were based on data from 79 patients with a median follow-up of 49 months.
RT ups diabetes risk in gastroduodenal indolent lymphoma
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.